Vor Biopharma (VOR)
US Market

Vor Biopharma (VOR) Balance Sheet


Vor Biopharma Balance Sheet

Vor Biopharma's total assets for Q3 2023 were $223.02M, a decrease of -11.14% from the previous quarter. VOR total liabilities were $48.24M for the fiscal quarter, a 3.67% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Assets
$ 299.37M$ 242.59M$ 75.91M$ 9.83M$ 1.01M
Total Liabilities
$ 48.76M$ 26.33M$ 134.97M$ 27.25M$ 7.78M
Total Equity Gross Minority
$ 250.61M$ 216.26M$ -59.06M$ -17.43M$ -6.77M
Total Capitalization
$ 250.61M$ 216.26M$ -59.06M$ -17.43M$ -6.77M
Preferred Stock Equity
--$ 107.34M$ 25.07M$ 2.00K
Capital Lease Obligations
--$ 18.29M$ 0.00-
Currency in USD

Vor Biopharma Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis